These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 24200616)

  • 1. [Interferons and autoimmune diseases].
    Niino M; Miyazaki Y
    Brain Nerve; 2013 Nov; 65(11):1381-8. PubMed ID: 24200616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interferon lambda in inflammation and autoimmune rheumatic diseases.
    Goel RR; Kotenko SV; Kaplan MJ
    Nat Rev Rheumatol; 2021 Jun; 17(6):349-362. PubMed ID: 33907323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmune manifestations during interferon therapy in patients with chronic hepatitis C: the hepatologist's view.
    Pellicano R; Smedile A; Peyre S; Astegiano M; Saracco G; Bonardi R; Rizzetto M
    Minerva Gastroenterol Dietol; 2005 Mar; 51(1):55-61. PubMed ID: 15756146
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overview of the biology of type I interferons.
    Kalliolias GD; Ivashkiv LB
    Arthritis Res Ther; 2010; 12 Suppl 1(Suppl 1):S1. PubMed ID: 20392288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type III Interferons (Lambda Interferons) in Rheumatic Autoimmune Diseases.
    Mora-Arias T; Amezcua-Guerra LM
    Arch Immunol Ther Exp (Warsz); 2020 Jan; 68(1):1. PubMed ID: 31915933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type I interferons in systemic autoimmunity.
    Sozzani S; Bosisio D; Scarsi M; Tincani A
    Autoimmunity; 2010 Apr; 43(3):196-203. PubMed ID: 20298124
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic potential of STAT4 in autoimmunity.
    Liang Y; Pan HF; Ye DQ
    Expert Opin Ther Targets; 2014 Aug; 18(8):945-60. PubMed ID: 24844303
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-alpha and -beta in kidney inflammation.
    Anders HJ; Lichtnekert J; Allam R
    Kidney Int; 2010 May; 77(10):848-54. PubMed ID: 20237459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferons and autoimmune disorders.
    Meyer O
    Joint Bone Spine; 2009 Oct; 76(5):464-73. PubMed ID: 19773191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The type I interferons: Basic concepts and clinical relevance in immune-mediated inflammatory diseases.
    López de Padilla CM; Niewold TB
    Gene; 2016 Jan; 576(1 Pt 1):14-21. PubMed ID: 26410416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The interferon-inducible HIN-200 gene family in apoptosis and inflammation: implication for autoimmunity.
    Mondini M; Costa S; Sponza S; Gugliesi F; Gariglio M; Landolfo S
    Autoimmunity; 2010 Apr; 43(3):226-31. PubMed ID: 20187706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Pathogenesis, Molecular Mechanisms, and Therapeutic Potential of the Interferon Pathway in Systemic Lupus Erythematosus and Other Autoimmune Diseases.
    Ramaswamy M; Tummala R; Streicher K; Nogueira da Costa A; Brohawn PZ
    Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferons as pathogenic effectors in autoimmunity.
    Baccala R; Kono DH; Theofilopoulos AN
    Immunol Rev; 2005 Apr; 204():9-26. PubMed ID: 15790347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shared and Distinct Functions of Type I and Type III Interferons.
    Lazear HM; Schoggins JW; Diamond MS
    Immunity; 2019 Apr; 50(4):907-923. PubMed ID: 30995506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon alpha and its contribution to autoimmunity.
    Selmi C; Lleo A; Zuin M; Podda M; Rossaro L; Gershwin ME
    Curr Opin Investig Drugs; 2006 May; 7(5):451-6. PubMed ID: 16729722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights into IL-29: Emerging role in inflammatory autoimmune diseases.
    Wang JM; Huang AF; Xu WD; Su LC
    J Cell Mol Med; 2019 Dec; 23(12):7926-7932. PubMed ID: 31578802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic potential of targeting TBK1 in autoimmune diseases and interferonopathies.
    Hasan M; Yan N
    Pharmacol Res; 2016 Sep; 111():336-342. PubMed ID: 27353409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Interferons].
    Pape GR
    Schweiz Rundsch Med Prax; 1992 Sep; 81(36):1039-40. PubMed ID: 1384099
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dendritic cells and interferon-mediated autoimmunity.
    Gottenberg JE; Chiocchia G
    Biochimie; 2007; 89(6-7):856-71. PubMed ID: 17562353
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies.
    Maddur MS; Miossec P; Kaveri SV; Bayry J
    Am J Pathol; 2012 Jul; 181(1):8-18. PubMed ID: 22640807
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.